597 related articles for article (PubMed ID: 29208743)
1. Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.
Krishna BA; Poole EL; Jackson SE; Smit MJ; Wills MR; Sinclair JH
mBio; 2017 Dec; 8(6):. PubMed ID: 29208743
[TBL] [Abstract][Full Text] [Related]
2. Human Cytomegalovirus US28 Ligand Binding Activity Is Required for Latency in CD34
Crawford LB; Caposio P; Kreklywich C; Pham AH; Hancock MH; Jones TA; Smith PP; Yurochko AD; Nelson JA; Streblow DN
mBio; 2019 Aug; 10(4):. PubMed ID: 31431555
[TBL] [Abstract][Full Text] [Related]
3. Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency.
Elder EG; Krishna BA; Williamson J; Lim EY; Poole E; Sedikides GX; Wills M; O'Connor CM; Lehner PJ; Sinclair J
mBio; 2019 Dec; 10(6):. PubMed ID: 31796538
[TBL] [Abstract][Full Text] [Related]
4. Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.
Humby MS; O'Connor CM
J Virol; 2015 Dec; 90(6):2959-70. PubMed ID: 26719258
[TBL] [Abstract][Full Text] [Related]
5. Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies.
De Groof TWM; Elder EG; Lim EY; Heukers R; Bergkamp ND; Groves IJ; Wills M; Sinclair JH; Smit MJ
Nat Commun; 2021 Jul; 12(1):4436. PubMed ID: 34290252
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.
Groves IJ; Jackson SE; Poole EL; Nachshon A; Rozman B; Schwartz M; Prinjha RK; Tough DF; Sinclair JH; Wills MR
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619107
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.
Krishna BA; Humby MS; Miller WE; O'Connor CM
Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1755-1764. PubMed ID: 30647114
[TBL] [Abstract][Full Text] [Related]
9. The HCMV US28 vGPCR induces potent Gαq/PLC-β signaling in monocytes leading to increased adhesion to endothelial cells.
Wu SE; Miller WE
Virology; 2016 Oct; 497():233-243. PubMed ID: 27497185
[TBL] [Abstract][Full Text] [Related]
10. Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus Reactivation.
Jackson SE; Chen KC; Groves IJ; Sedikides GX; Gandhi A; Houldcroft CJ; Poole EL; Montanuy I; Mason GM; Okecha G; Reeves MB; Sinclair JH; Wills MR
Front Immunol; 2021; 12():657945. PubMed ID: 33912186
[TBL] [Abstract][Full Text] [Related]
11. Activator protein-1 transactivation of the major immediate early locus is a determinant of cytomegalovirus reactivation from latency.
Krishna BA; Wass AB; O'Connor CM
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20860-20867. PubMed ID: 32788362
[TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor Alpha Induces Reactivation of Human Cytomegalovirus Independently of Myeloid Cell Differentiation following Posttranscriptional Establishment of Latency.
Forte E; Swaminathan S; Schroeder MW; Kim JY; Terhune SS; Hummel M
mBio; 2018 Sep; 9(5):. PubMed ID: 30206173
[TBL] [Abstract][Full Text] [Related]
13. The Requirement for US28 During Cytomegalovirus Latency Is Independent of US27 and US29 Gene Expression.
Krishna BA; Wass AB; Sridharan R; O'Connor CM
Front Cell Infect Microbiol; 2020; 10():186. PubMed ID: 32411622
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
[TBL] [Abstract][Full Text] [Related]
15. A BMPR2/YY1 Signaling Axis Is Required for Human Cytomegalovirus Latency in Undifferentiated Myeloid Cells.
Poole E; Carlan da Silva MC; Huang C; Perera M; Jackson S; Groves IJ; Wills M; Rana A; Sinclair J
mBio; 2021 Jun; 12(3):e0022721. PubMed ID: 34061599
[TBL] [Abstract][Full Text] [Related]
16. The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
Wills MR; Poole E; Lau B; Krishna B; Sinclair JH
Cell Mol Immunol; 2015 Mar; 12(2):128-38. PubMed ID: 25132454
[TBL] [Abstract][Full Text] [Related]
17. Selective 4-Thiouracil Labeling of RNA Transcripts within Latently Infected Cells after Infection with Human Cytomegalovirus Expressing Functional Uracil Phosphoribosyltransferase.
Roche KL; Nukui M; Krishna BA; O'Connor CM; Murphy EA
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089702
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus reactivation from latency: validation of a "switch" model in vitro.
Arcangeletti MC; Vasile Simone R; Rodighiero I; De Conto F; Medici MC; Maccari C; Chezzi C; Calderaro A
Virol J; 2016 Oct; 13(1):179. PubMed ID: 27770817
[TBL] [Abstract][Full Text] [Related]
19. Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.
Krishna BA; Spiess K; Poole EL; Lau B; Voigt S; Kledal TN; Rosenkilde MM; Sinclair JH
Nat Commun; 2017 Feb; 8():14321. PubMed ID: 28148951
[TBL] [Abstract][Full Text] [Related]
20. Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation.
Medica S; Crawford LB; Denton M; Min CK; Jones TA; Alexander T; Parkins CJ; Diggins NL; Streblow GJ; Mayo AT; Kreklywich CN; Smith P; Jeng S; McWeeney S; Hancock MH; Yurochko A; Cohen MS; Caposio P; Streblow DN
PLoS Pathog; 2023 Oct; 19(10):e1011682. PubMed ID: 37782657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
